AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $478,000 | +51.7% | 50,100 | +47.8% | 0.00% | – |
Q2 2021 | $315,000 | -43.0% | 33,900 | -25.9% | 0.00% | -100.0% |
Q3 2018 | $553,000 | -71.7% | 45,769 | -63.5% | 0.00% | -66.7% |
Q2 2018 | $1,956,000 | +19.0% | 125,227 | +14.5% | 0.00% | 0.0% |
Q1 2018 | $1,644,000 | -47.5% | 109,327 | -49.8% | 0.00% | -40.0% |
Q4 2017 | $3,133,000 | -7.9% | 217,754 | -3.4% | 0.01% | 0.0% |
Q3 2017 | $3,400,000 | +178.7% | 225,454 | +86.1% | 0.01% | +150.0% |
Q2 2017 | $1,220,000 | +36.2% | 121,160 | -3.6% | 0.00% | +100.0% |
Q1 2017 | $896,000 | +25.7% | 125,660 | -12.4% | 0.00% | 0.0% |
Q4 2016 | $713,000 | -23.1% | 143,460 | +14.5% | 0.00% | -50.0% |
Q3 2016 | $927,000 | -1.4% | 125,260 | -27.2% | 0.00% | 0.0% |
Q2 2016 | $940,000 | -35.9% | 172,100 | -0.9% | 0.00% | -33.3% |
Q1 2016 | $1,467,000 | -15.3% | 173,600 | -2.9% | 0.00% | 0.0% |
Q4 2015 | $1,733,000 | -29.7% | 178,700 | +1.5% | 0.00% | -40.0% |
Q3 2015 | $2,464,000 | +1.1% | 176,100 | +2.2% | 0.01% | +25.0% |
Q2 2015 | $2,438,000 | – | 172,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |